OC-0563: MRI based 3D reconstruction of pharyngeal cancer to aid clinical oncologists in radiotherapy treatment planning  by Doshi, T. et al.
3rd ESTRO Forum 2015                                                                                                                                         S275 
 
 
Conclusions: PET/CT with low dose FDG provides good image 
quality and is a promising method for frequent monitoring of 
tumour response during CCRT, with reduced imaging dose and 
cost relative to standard PET/CT. A multidisciplinary 
approach in protocol development and image acquisition is 
essential to derive safe and efficient workflows. 
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Purpose/Objective: Magnetic resonance imaging (MRI) is 
increasingly becoming the preferred modality for 
radiotherapy treatment planning (RTP) of oropharynx and 
larynx cancer due to its excellent soft tissue contrast. Two 
dimensional (2D) outlines of these cancer regions from 
sequential axial MRI slices restrict the view of cancer regions 
with respect to other anatomical structures. Three 
dimensional (3D) volume reconstruction of cancer from 
contiguous MRI slices help oncologists to understand the 
complex structure of cancer with a greater degree of 
certainty. 3D views allow oncologists to understand the 
geometry, margin and specific morphological features of 
cancer regions from different angles. In this work we use a 
novel Level Set based method to automatically reconstruct 
2D oropharynx and larynx cancer boundaries from real MRI 
slices, for 3D visualisation and subsequent quantification. 
Materials and Methods: Axial gadolinium-enhanced T1-
weighted (T1+Gd) MRI scans were obtained for 2 patients 
with pharyngeal cancer. Contours of cancer region from 12 
contiguous MRI slices of oropharynx cancer and 7 contiguous 
MRI slices of larynx cancer were obtained, using our new 
automatic processing method, and then compared to the 
contours defined manually by clinical experts. Information 
from DICOM header, such as slice location, slice thickness and 
spacing in between slices, is used to reconstruct cancer in 
3D. For this, each contour is sampled into uniformly spaced 
100 points. These contours are stacked to produce the 3D 
dataset. Furthermore 2 additional contours are inserted in-
between real contours using a conventional spline 
interpolation technique. 3D cancer region is reconstructed 
from these contours using rectangular mesh. 
Results: The agreement between manual and automatic 
contours was estimated by the dice similarity coefficient 
(DSC). The DSC for all 19 slices is shown in Table1. It can be 
observed that most slices have value greater than 0.75, 
except the first or last slices where cancer region is small, 
hence the DSC value is small. The average DSC value for 2 
patients is 0.82. Fig.1 shows the 3D view of oropharynx and 
larynx cancer regions. From Fig.1 it is clear that 3D 
reconstructed cancer region from automatic and manual 
contours are comparable. The average error between 
automatic volume and manual volume1 is 4.62% using manual 
volume1 as reference. This error is 9.52% between manual 
volume1 and manual volume2 using manual volume1 as 
reference. The tumor-cut technique developed in 2012 for 3D 
brain tumour segmentation from T1+Gd MRI demonstrates 
volume error of 5.7% for two best cases which is comparable 
with this automatic technique. 
Conclusions: This reconstruction tool produces smooth, 
acceptable 3D surface for cancerous regions. The 
reconstructed surfaces provide oncologists with additional 
information not easily available from simple 2D MRI slices, 
about cancer regions. It is anticipated that this will lead to 
improved RTP.  
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